HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

fuligocandin B

a natural cycloanthranilylproline derivative from extract of myxomycete Fuligo candida; structure in first source

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Cyclic Amino Acids: 3
    - Imino Acids: 11
      - Proline: 3391
        fuligocandin B: 2

Experts

1.	Ishibashi, Masami: 2 articles (12/2016 - 09/2007)
2.	Arai, Midori A: 1 article (12/2016)
3.	Kado, Sayaka: 1 article (12/2016)
4.	Komatsuzaki, Kazuhiro: 1 article (12/2016)
5.	Masuda, Ayaka: 1 article (12/2016)
6.	Sampei, Mana: 1 article (12/2016)
7.	Satoh, Mamoru: 1 article (12/2016)
8.	Taguchi, Shota: 1 article (12/2016)
9.	Uchiyama, Kento: 1 article (12/2016)
10.	Hasegawa, Hiroo: 1 article (09/2007)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 12/01/2016 - "We synthesized enatiomerically pure fuligocandin B (2) and its derivative 5'-I fuligocandin B (4), and found that the latter had an improved biological activity against the human gastric cancer cell line, AGS. "
2.	Leukemia 09/01/2007 - "A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production."

Related Drugs and Biologics

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2.	Ligands
3.	cycloanthranilylproline
4.	9-deoxy-delta-9-prostaglandin D2